ALK-driven tumors and targeted therapy: focus on crizotinib

Overview of attention for article published in Pharmacogenomics and Personalized Medicine, March 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)

Mentioned by

blogs: 1 blog
twitter: 2 X users

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 48 Mendeley

Summary Blogs X Wikipedia Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 41 followers.

ALK-driven tumors and targeted therapy: focus on crizotinib http://t.co/ixybp8DDkR

Reply Repost Favourite

ALK-driven tumors and targeted therapy: focus on crizotinib http://t.co/72eTr6Loec

Reply Repost Favourite